February 7, 2023
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed, and higher odds were associated with Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health, published Feb. 2 in the Journal of Infectious Diseases.
November 1, 2022
The National Geographic cited the Texas CARES article “Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents” in its recent look at long COVID in children around the world.
September 9, 2022
Texas CARES researchers determined a way to estimate antibodies to COVID-19 infections and COVID-19 vaccinations in people living in a large region. The findings were published in PLOS ONE.
August 1, 2022
The Texas CARES team examined the presence of persistent COVID symptoms — or long COVID — in children by COVID-19 antibody status between October 202 and May 2022. The article was published in The Pediatric Infectious Disease Journal.
May 27, 2022
Texas CARES researchers examined how long antibodies from a COVID-19 infection lasted in participants ages 5-19 years old. The findings were published in Pediatrics.
May 6, 2022
The Texas CARES team examined how long antibodies from a COVID-19 infection lasted among Texas CARES participants. The findings were published in The Journal of Infectious Diseases.
December 14, 2021
The Texas CARES team examined results from Phase I of the Texas CARES survey. The findings were published in Frontiers in Public Health.